Company Profile
UnitedHealth Group Stock Price, News & Analysis
- Ticker:
- UNH
- Exchange:
- NYSE
- Sector:
- Healthcare Services
- Location:
- United States
Stock performance
403.97 USD (-2.13%)
Close
Last updated: August 6, 2026
343B USD
Market cap
Why the stock is moving
Following the latest company update, “Corbus Pharmaceuticals Reports Q2 2026 Financial Results and Provides a Corporate Update”, UNH closed down 2.13% at $403.97 on Aug 6, 2026. The move occurred in the trading session associated with this earnings update.
Company overview
Business overview
UnitedHealth Group is a diversified healthcare company with insurance, care delivery, and services operations through UnitedHealthcare and Optum. The company’s story is driven more by managed-care scale, services growth, and operating execution than by classic biotech catalysts.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NYSE, UnitedHealth sits in managed care and healthcare services. Its geographic footprint is broad and largely U.S.-centered, with a large national commercial presence.
Business Model Characteristics
The business combines premium revenue, healthcare services, data-enabled operations, and care delivery infrastructure. Investors tend to watch membership trends, medical cost ratios, Optum growth, and regulatory or reimbursement pressure.
Position Within the Biotechnology Landscape
UnitedHealth is not a biotech company, but it matters to healthcare investors because it sits at the center of payer and provider economics. Its stock is driven by operational and policy factors rather than drug-development catalysts.
Future catalysts
UnitedHealth Group's catalyst setup now looks most tied to CRB-701, CANYON-1, and the rest of its current pipeline. What gives this more shape is “Having reached broad alignment with the FDA, we’re on track to start a registrational study for CRB-701 in second-line HNSCC this summer. That setup makes the next update more important than the headline financials themselves.
Recent news
- 01
Corbus Pharmaceuticals Reports Q2 2026 Financial Results and Provides a Corporate Update
Source: UnitedHealth Group
- 02
- 03
- 04
Corbus Pharmaceuticals Appoints Leonardo Viana Nicacio, M.D. as Chief Medical Officer
Source: UnitedHealth Group
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of UnitedHealth Group (UNH)?
UnitedHealth Group (UNH) most recently closed at 403.97 USD, a -2.13% move versus the previous session.
What is the market cap of UnitedHealth Group (UNH)?
UnitedHealth Group currently has a market capitalization of 343B USD on BioPharmSignal.
What does UnitedHealth Group do?
UnitedHealth Group is a diversified healthcare company with insurance, care delivery, and services operations through UnitedHealthcare and Optum. The company’s story is driven more by managed-care scale, services growth, and operating execution than by classic biotech catalysts.
On which exchange is UNH stock listed?
UnitedHealth Group (UNH) is associated with NYSE, United States, Healthcare Services.
What is CRB-701?
UnitedHealth Group's catalyst setup now looks most tied to CRB-701, CANYON-1, and the rest of its current pipeline.
Which conditions is UnitedHealth Group targeting with CRB-701?
UnitedHealth Group's catalyst setup now looks most tied to CRB-701, CANYON-1, and the rest of its current pipeline.
How does UnitedHealth Group describe recent progress with CRB-701?
UnitedHealth Group's catalyst setup now looks most tied to CRB-701, CANYON-1, and the rest of its current pipeline.
What is CANYON-1?
UnitedHealth Group's catalyst setup now looks most tied to CRB-701, CANYON-1, and the rest of its current pipeline.